Safety and efficacy of VRC01 broadly neutralising antibodies in adults with acutely treated HIV (RV397): a phase 2, randomised, double-blind, placebo-controlled trial
- Resource Type
- Article
- Source
- The Lancet HIV; May 2019, Vol. 6 Issue: 5 pe297-e306, 10p
- Subject
- Language
- ISSN
- 24054704; 23523018